References
- Briton J R, Burney P G, Chinn S, Paracosta A, Tattersfield A E. The relationship between change in airway reactivity and change in respiratory symptoms and medication in a community study. Am Rev Respir Dis 1988; 138: 530–534
- Harvey J E, Tattersfield A E. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic and asthmatic subjects. Thorax 1982; 37: 280–287
- Holgate S T, Stubbs W A, Wood P J, McCaughey E S, Alberti K GMM, Tattersfield A E. Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci 1980; 59: 155–161
- Harvey J E, Baldwin C J, Wood P J, Alberti K GMM, Tattersfield A E. Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci 1981; 60: 579–585
- Barnes P J, Pride N B. Dose response curves to inhaled beta‐adrenoceptor agonist in normal and asthmatic subjects. Br J Clin Pharmacol 1983; 15: 677–682
- Boskabady M H, Snashall P D. Bronchial responsiveness to beta‐adrenergic stimulation and enhanced beta‐blockade in asthma. Respirology 2000; 5: 111–118
- Krzanowski J J, Szentivanyi A. Reflections on some aspects of current research in asthma. J Allergy Clin Immunol 1983; 72: 433–442
- Heaton R W, Gillett M K, Snashall P D. Morning–evening changes in airway responsiveness to methacholine in normal and asthmatic subjects; analysis using partial flow volume curves. Thorax 1988; 43: 727–728
- Gillet M K, Snashall P D. Measurement of pharmacological antagonism produced by atropine in bronchi of normal and asthmatic subjects. Eur Respir J 1988; 1: 27–33
- American Thoracic Society. Standardization of spirometry: 1994 Update. Official Statement of American Thoracic Society. Am J Respir Crit Car Med 1995; 152: 1107–1136
- Gillett M K, Briggs B A, Snashall P D. The Influence of aerosol retention and pattern of deposition on bronchial responsiveness to atropine and methacholine. Am Rev Respir Dis 1989; 140: 1727–1733
- Boskabady M H, Snashall P D. Histamine (H1) receptor affinity and bronchial responsiveness to histamine in man. Med J Islam Rep Iiran 1997; 11: 115–122
- Ahrens R C, Smith G D. Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use. Pharmacotherapy 1984; 4: 105–121
- Sterk P G, Bel E H. (1989). Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1984; 2: 267–274, 1989
- Trigg C J, Bennett J B, Tooly M, Sibbald B, D'souza M F, Davis R J. A general practice based survey of bronchial hyperresponsiveness and its relations to symptoms, sex, age atopy and smoking. Thorax 1990; 45: 866–872
- Chung K F, Jeyasingh K, Snashall P D. Influence of airway calibre on the intra‐pulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J 1988; 1: 890–895
- Pendry Y D. Neural control of airways smooth muscle. Pharmac Ther 1993; 57: 171–202
- Cryer P E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Eng J Med 1980; 303: 436–444
- McNeill R S. Effect of a beta‐adrenergic blocking agent propranolol on asthmatics. Lancet 1964; 2: 1101
- Zaid G, Beall G N. Bronchial response to beta‐adrenergic blockade. New Eng J Med 1966; 275: 580–584
- Townley R G, McGeady S, Bewta A. The effect of beta‐adrenergic blockade on bronchial sensitivity to acetyl‐beta‐methacholine in normal and allergic rhinits subjects. J Allergy Clin Immunol 1976; 57: 358–366
- Richardson P S, Sterling G M. Effects of beta‐adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects. Br Med J 1969; 3: 143–145
- Holroyde M C. The influence of epithelium on the responsiveness of guinea‐pig isolated trachea. Br J Pharmacol 1986; 87: 501–507
- Benson M K. Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airway obstruction. Thorax 1978; 33: 211–213